Rosenblatt's downgrade of Coherent to Neutral from Buy indicates a shift in their outlook for the stock. However, the raised price target from $41 to $55 suggests that they still see potential for growth. The short-term impact on the stock price is likely to be neutral as the downgrade and increased price target balance each other out.